News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
《業績》四環醫藥(00460.HK)全年虧轉盈賺1.8億元人幣 末期息0.96分人幣
四環醫藥(00460.HK)公布截至去年12月底止全年業績，營業額26.18億元人民幣(下同)，按年升37.7%。虧轉盈賺1.8億元，上年同期蝕2.17億元；每股盈利1.97分。派末期息0.96分，上年同期不派息。(ha/u)~阿思達克財經新聞網址: www.aastocks.com
Reset
Send
The window will close in 5 seconds
《業績》四環醫藥(00460.HK)全年虧轉盈賺1.8億元人幣 末期息0.96分人幣
Close
Recommend
18
Positive
20
Negative
8
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get NVDA share!

四環醫藥(00460.HK)  -0.040 (-2.759%)    Short selling $7.55M; Ratio 54.367%   公布截至去年12月底止全年業績，營業額26.18億元人民幣(下同)，按年升37.7%。虧轉盈賺1.8億元，上年同期蝕2.17億元；每股盈利1.97分。派末期息0.96分，上年同期不派息。(ha/u)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-04-02 16:25.)

Dividend History
Announce DateEventParticular
2025/09/04SpecialPreferential Offer: Assured entitlement 1 XuanZhu Biopharmaceutical Co., Ltd. reserved share for every integral multiple of 2728 shares
2025/08/29InterimD:RMB 0.0099 (Equivalent to approximately HKD 0.0109)
2025/03/28FinalNo Dividend
2024/08/30InterimD:RMB 0.0190 (Equivalent to approximately HKD 0.021)

AASTOCKS新聞

Switch to Auto-Translated Version
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.